Deflazacort Suspension Suppliers & Bulk Manufacturers
Available Forms: Oral suspension
Available Strengths: 22.75 mg/ml
Reference Brands: Emflaza (USA)
Category:
Transplant
Deflazacort is a corticosteroid. It increases the level of glucocorticoid in the body and works by decreasing the formation of substances that cause inflammation and suppresses immunity to stop self-damage to the body by the immune system (auto-immune reactions occurring in organ transplants or cancer).
Deflazacort suspension is available in Oral suspension
and strengths such as 22.75 mg/ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Deflazacort suspension is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Deflazacort suspension can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Deflazacort Oral Suspension is a corticosteroid medication used to manage a variety of conditions that involve inflammation or an overactive immune response. It is commonly prescribed for allergies, asthma, joint and muscle diseases, and other inflammatory or autoimmune disorders. The suspension formulation allows for easier dosing, especially in patients who have difficulty swallowing tablets, including children. Deflazacort works by binding to glucocorticoid receptors, modulating gene expression, and reducing the production of inflammatory mediators in the body. This results in decreased inflammation, alleviation of symptoms, and improved overall function in affected tissues. It provides a convenient and effective option for long-term or short-term corticosteroid therapy under medical supervision.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing